We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more
Ep8.5
Epicatechin Research
Probably helpsHigh safety
39 peer-reviewed studies
What the evidence says
Probably helps
Epicatechin helped in about half (10/17) of the studies that measured an effect — promising, but not unanimous.
Most evidence is from high-quality meta-analyses and randomised trials published 2005–2026 with a typical study size of 410 participants.
Based on 39 studies · 7 meta-analyses · 19 RCTs · 1,081,306 total participants
Confidence
High
What the studies found
10helped7unclear· 22 more without graded effect data
By outcome
Cardiovascular & endothelialImproves endothelial function and nitric oxide production · 4-8 weeks
24 studies in the last 5 years · Latest meta-analysis: 2026
200520152026
1Office systolic blood pressureMeta-AnalysisCited 6×n=5,205 · very large study2025
Flavan-3-ol-rich foods considerably reduce elevated BP and improve endothelial function independent of blood pressure supporting their use for cardiovascular prevention.
Lagou V et al. · European journal of preventive cardiology (2025)
Noticeable benefit
← WorseNo effectBetter →
Flavan-3-ol interventions included epicatechin, epigallocatechin-gallate, cocoa products, tea, grape extract, and apples delivering 586 mg (95% CI 510, 662) total flavan-3-ols.
Interventions decreased office (-2.8 [95% CI -3.9, -1.7]/-2.0 [-2.6, -1.3] mmHg) and 24 h-ambulatory BP (-3.7 [-5.8, -1.6]/-2.6 [-4.5, -0.8] mmHg) after chronic repetitive consumption.
Flow-mediated dilation increased after acute (+2.0% [1.6, 2.3]) and repetitive (+1.7% [1.3, 2.2]) consumption independent of BP.
Collectively, the results highlight that epicatechin has the therapeutic potential for preventing or mitigating oxidative stress-related cognitive dysfunction.
Yoon YC et al. · Journal of agricultural and food chemistry (2025)
At the molecular level, epicatechin treatment increased the expression or activity of superoxide dismutase, catalase, and nuclear factor erythroid 2-related factor 2 and reduced the levels of nitric oxide, malondialdehyde, tumor necrosis factor-alpha, and interleukin-1 beta.
These findings support the role of epicatechin in enhancing antioxidant defense and modulating neuroinflammation.
Collectively, the results highlight that epicatechin has the therapeutic potential for preventing or mitigating oxidative stress-related cognitive dysfunction.
5CrossFit performanceSystematic ReviewCited 19×n=219 · medium study2021
These outcomes may have been obtained due to methodological limitations such as small sample size, lack of control over influencing variables, short period of exercise intervention.
Dos Santos Quaresma MVL et al. · Nutrition (Burbank, Los Angeles County, Calif.) (2021)
These outcomes may have been obtained due to methodological limitations such as small sample size, lack of control over influencing variables, short period of exercise intervention.
Despite the popularity and growing evidence about CF, little is known about the relationship between performance-enhancing substances or dietary interventions and CF performance.
Given the lack of scientific evidence, new studies with potential ergogenic supplements, a better methodological model, and practical application are required.
However, there is no protocol standardization or enough clinical evidence to draw more specific conclusions on its therapeutic implementation.
German IJS et al. · Nutrients (2024)
Epicatechin showed positive effects on follistatin and on the stimulation of factors related to the myogenic actions (MyoD, Myf5, and myogenin).
Furthermore, the literature also showed that epicatechin can interfere with mitochondrias' biosynthesis in muscle fibers, stimulation of the signaling pathways of AKT/mTOR protein production, and amelioration of skeletal musculature performance, particularly when combined with physical exercise.
Epicatechin can, for these reasons, exhibit clinical applicability due to the beneficial results under conditions that negatively affect the skeletal musculature.
Flavonoids may have a great potential to treat sarcopenia.
Wu C et al. · Nutrients (2023)
Skeletal muscle mass significantly increased in three studies, muscle strength significantly elevated in two studies, and physical performance significantly improved in two studies.
RCTs evaluated the main outcomes of tea catechins, epicatechin, and isoflavones intervention.
The majority of studies (five in six) found at least one of the main outcomes is elevated by flavonoids intervention.
They contributed to the bioavailability of flavan-3-ols for over 20%.
Di Pede G et al. · Molecular aspects of medicine (2023)
No clear effect
← WorseNo effectBetter →
They contributed to the bioavailability of flavan-3-ols for over 20%.
Mean bioavailability for flavan-3-ols was moderate (31 ± 23%, n bioavailability values = 20), and it seems to be scarcely affected by the amount of ingested compounds.
This highlights the need to better clarify the metabolic yield with which monomer flavan-3-ols and proanthocyanidins are metabolized in humans.
9Kidney stone prevention and managementMeta-AnalysisCited 108×2018
Further investigations are required to confirm the safety and efficacy of these compounds.
Nirumand MC et al. · International journal of molecular sciences (2018)
The main underlying mechanisms of these dietary plants and their isolated phytonutrients in the management of urolithiasis include diuretic, antispasmodic, and antioxidant activity, as well as an inhibitory effect on crystallization, nucleation, and aggregation of crystals.
The results as presented in this review demonstrate the promising role of dietary plants and phytophenols in the prevention and management of kidney stones.
Further investigations are required to confirm the safety and efficacy of these compounds.
10Cardiometabolic parametersSystematic ReviewCited 9×n=11 · very small study2022
Unbiased RCTs on the impact of an EC intake are needed, which should also investigate the additive or synergistic effects of EC with other cocoa ingredients.
Dicks L et al. · Nutrients (2022)
For most trials, some concerns exist for overall RoB.
Thus, EC intake may improve endothelial function in healthy young adults.
For further parameters (mostly secondary outcomes), it remains unclear if EC has no effect or if this was not detectable.
However, the available evidence is very diverse and future studies may address the identified sources of variation to strengthen current evidence on this promising field.
Barrera-Reyes PK et al. · Plant foods for human nutrition (Dordrecht, Netherlands) (2020)
Memory (n = 5) and executive function (n = 4) showed the most significant effects with medium and large effect sizes after intake of intermediate doses of cocoa flavanols (500-750 mg/day).
Effects on cognitive function were observed after consumption of 50 mg/day of (-)-epicatechin and in studies using a component-matched placebo and cocoa as the polyphenol vehicle given to healthy adults (18-50 years).
Overall, this set of studies suggest a positive effect of cocoa polyphenols on memory and executive function.
This meta-analysis provides evidence that cocoa flavanols could significantly improve endothelial function, with an optimal effect observed with 710 mg total flavanols, 95 mg (-)-epicatechin or 25 mg (+)-catechin.
Sun Y et al. · Food & function (2019)
Barely noticeable benefit
← WorseNo effectBetter →
A significant improvement of FMD by 1.17% (95% CI: 0.76% to 1.57%) was calculated, with strong evidence of a non-linear association (inverted U-shape) between cocoa flavanols and FMD.
This meta-analysis provides evidence that cocoa flavanols could significantly improve endothelial function, with an optimal effect observed with 710 mg total flavanols, 95 mg (-)-epicatechin or 25 mg (+)-catechin.
However, there was substantial variation in the results that could not be explained by the characteristics that we explored, and there were significant risk-of-bias concerns with a large majority of the studies.
The present analysis suggests that flavonoid bioactivity does not follow a classical linear dose-response association and this may have important biological implications.
Kay CD et al. · Molecular nutrition & food research (2012)
The present analysis suggests that flavonoid bioactivity does not follow a classical linear dose-response association and this may have important biological implications.
Based on available information, maximum health benefits may be achieved if mature Sorbus domestica L. fruits are consumed approximately two weeks after harvest or as unripe fruit-based fermented products.
Penzes N et al. · Nutrients (2026)
Despite existing preclinical evidence, there is a significant gap in clinical trials evaluating the direct impact of polyphenols mentioned above on bone health in humans.
Therefore, further research is needed to confirm their effectiveness in clinical settings.
The therapeutic potential of the most common polyphenols from Sorbus domestica L. fruits has been evaluated by available in vitro and in vivo studies, which highlight their promising potential as dietary interventions to prevent bone loss and improve skeletal integrity in metabolic bone diseases.
Pathak G et al. · Phytotherapy research : PTR (2026)
Compounds such as quercetin, catechin, naringenin, and epicatechin have shown significant improvements in glycemic parameters and antioxidant enzymes in both preclinical and clinical studies.
However, challenges remain regarding bioavailability, optimal dosing, and safety profiles, particularly in vulnerable populations, including pregnant women.
Future directions should prioritize nano-formulations to improve pharmacokinetics.
16Cardiovascular and liver disease risk factorsSystematic Review2026
Further large-scale, long-term trials are needed to confirm these beneficial effects and to standardize the dosage and formulation of cocoa flavanols.
Tomaru JM et al. · Nutrients (2026)
These findings suggest a potential role for cocoa flavanol-rich dark chocolate in cardiometabolic health; however, the evidence remains preliminary and is limited by heterogeneous study designs, small sample sizes, and short intervention durations.
Despite these limitations, current evidence supports the inclusion of moderate dark chocolate consumption as a possible adjunct strategy to mitigate cardiometabolic and hepatic metabolic risks.
Further large-scale, long-term trials are needed to confirm these beneficial effects and to standardize the dosage and formulation of cocoa flavanols.
17Epigenetic aging clocks (PCGrimAge)RCTn=958 · large study2026
Li S et al. · Nature medicine (2026)
Noticeable benefit
← WorseNo effectBetter →
MVM had a stronger effect on PCGrimAge among those with accelerated biological aging at baseline (-0.236 [-0.380 to -0.091]) compared with those with normal or decelerated biological aging (-0.013 [-0.130 to 0.104]; P = 0.018 for interaction).
Cocoa extract did not have an effect on the five epigenetic clocks tested.
18Age-related macular degeneration occurrenceRCTCited 1×n=666 · large study2025
In this ancillary study of the COSMOS randomized clinical trial, cocoa extract supplementation for a median period of 3.6 years among older women and men had no effect overall on occurrence of AMD.
Christen WG et al. · JAMA ophthalmology (2025)
No clear effect
← WorseNo effectBetter →
Could be chance
Mean (SD) participant age was 72.1 (6.6) years, and 12 666 participants (59.1%) were female.
During a median (IQR) period of 3.6 (3.2-4.2) years of treatment and follow-up, 344 participants (1.6%) experienced a confirmed AMD event (316 incident AMD, 28 progression to advanced AMD).
For the primary composite end point, there were 159 cases (1.5%) in the cocoa extract group and 185 cases (1.7%) in the placebo group (hazard ratio [HR], 0.87; 95% CI, 0.71-1.08; P = .21).
20Global cognitive functionRCTCited 10×n=573 · large study2024
Among 573 older adults who underwent repeat in-person, detailed neuropsychological assessments over 2 y, daily CE supplementation, compared with placebo, showed no overall benefits for global or domain-specific cognitive function.
Vyas CM et al. · The American journal of clinical nutrition (2024)
No clear effect
← WorseNo effectBetter →
Participants' mean age (standard deviation) was 69.6 (5.3); 49.2% were females.
Daily supplementation with CE, compared with placebo, had no significant effect on 2-y change in global cognition {mean difference [95% confidence interval (CI)]: -0.01 (-0.08, 0.05) standard deviation units (SU)}.
CE, compared with placebo, had no significant effects on 2-y change in episodic memory [mean difference (95% CI): -0.01 (-0.13, 0.10) SU] or executive function/attention [mean difference (95% CI): 0.003 (-0.07, 0.08) SU].